Autism Spectrum Disorder (ASD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Autism Spectrum Disorder Clinical Trials Market Overview
The Autism Spectrum Disorder (ASD) clinical trial market research report provides an overview of the Autism Spectrum Disorder (ASD) clinical trials scenario. This report provides top-line data relating to the clinical trials on ASD and includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report also offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. It provides prominent drugs for in-progress trials (based on the number of ongoing trials).
Key Regions | · Asia-Pacific
· Europe · North America · Middle East & Africa · South & Central America |
Key Countries | · The US
· China · Iran · Japan · Australia · The UK · India · The Netherlands · France · Canada |
Key Sponsor Types | · Institution
· Company · Government |
Leading Sponsors | · F. Hoffmann-La Roche Ltd
· Otsuka Holdings Co Ltd · Teva Pharmaceutical Industries Ltd · Johnson & Johnson · Autism Speaks Inc · Bristol-Myers Squibb Co · Seaside Therapeutics LLC (Inactive) · ICON Plc · Eli Lilly and Co · Jazz Pharmaceuticals Plc |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
ASD Clinical Trials Market Segmentation by Regions and Countries
Some of the key regions in the ASD clinical trials market are Asia-Pacific, Europe, North America, the Middle East & Africa, and South & Central America. North America dominates the market as of August 2023.
As of August 2023, in a country-wise analysis, the US has the highest number of ASD clinical trials, followed by China, Iran, Japan, Australia, the UK, India, the Netherlands, France, and Canada.
G7 countries: Among the G7 (United States, United Kingdom, Germany, France, Italy, Canada, and Japan) countries, the US has the highest proportion of Autism Spectrum Disorder (ASD) to Central Nervous System clinical trials as of August 2023. Moreover, most of the clinical trials are conducted in the US.
E7 countries: Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Indonesia has the highest proportion of Autism Spectrum Disorder (ASD) to Central Nervous System clinical trials as of August 2023. Out of all the clinical trials conducted in the E7 countries, the majority are in China.
ASD Clinical Trials Analysis by Regions, 2023 (%)
Buy Full Report for More Regional Insights into the ASD Clinical Trials Market
ASD Clinical Trials Market Segmentation by Sponsor Types
The key sponsor types in the ASD clinical trials market are institution, company, and the government. Out of them, the institution sponsor type dominates the market.
ASD Clinical Trials Market Analysis by Sponsor Types, 2023 (%)
Buy Full Report for More Sponsor Type Insights into ASD Clinical Trials Market
ASD Clinical Trials Market - Competitive Landscape
The leading sponsors in the ASD clinical trials market are F. Hoffmann-La Roche Ltd, Otsuka Holdings Co Ltd, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Autism Speaks Inc, Bristol-Myers Squibb Co, Seaside Therapeutics LLC (Inactive), ICON Plc, Eli Lilly and Co, and Jazz Pharmaceuticals Plc. F. Hoffmann-La Roche Ltd led the ASD clinical trials market in August 2023.
ASD Clinical Trials Market Analysis by Sponsors, 2023 (%)
Buy Full Report to Know More About the Leading Sponsors in the ASD Clinical Trials Market
Segments Covered in the Report
ASD Clinical Trials Regional Outlook (2023)
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South & Central America
ASD Clinical Trials Country Outlook (2023)
- The US
- China
- Iran
- Japan
- Australia
- The UK
- India
- The Netherlands
- France
- Canada
ASD Clinical Trials Sponsor Type Outlook (2023)
- Institution
- Company
- Government
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and end point status
- The report reviews the top companies involved and enlists all trials pertaining to the company
- The report provides all the unaccomplished trials with reasons for unaccomplishment
- The report provides enrollment trends for the past five years
- Report provides the latest news for the past three months
Reasons to Buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of the Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in the global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional, and country level
Otsuka Holdings Co Ltd
Teva Pharmaceutical Industries Ltd
Johnson & Johnson
Autism Speaks Inc
Bristol-Myers Squibb Co
Seaside Therapeutics LLC (Inactive)
ICON Plc
Eli Lilly and Co
Jazz Pharmaceuticals Plc
Table of Contents
Frequently asked questions
-
Which is the leading region in the ASD clinical trials market?
North America is the leading region in the ASD clinical trials market as of August 2023.
-
Which is the leading country in the ASD clinical trials market?
The US is the leading country in the ASD clinical trials market as of August 2023.
-
Which is the leading sponsor type in the ASD clinical trials market?
Institution is the leading sponsor type in the ASD clinical trials market as of August 2023.
-
Who are the leading sponsors in the ASD clinical trials market?
The leading sponsors in the ASD clinical trials market are F. Hoffmann-La Roche Ltd, Otsuka Holdings Co Ltd, Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Autism Speaks Inc, Bristol-Myers Squibb Co, Seaside Therapeutics LLC (Inactive), ICON Plc, Eli Lilly and Co, and Jazz Pharmaceuticals Plc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Autism reports

